CTHA和CTAP在肝癌介入治疗中的应用  

Application of CT hepatic arteriography and CT during arterial portography in interventional therapy of hepatocellular carcinoma

作　　者：李平[1] 周映梅[2] 谢太喜[1] 范磊[1] 

机构地区：[1]湖南中医药大学第一附属医院放射科,湖南长沙410007 [2]湖南中医药大学

出　　处：《中国中西医结合影像学杂志》2008年第5期344-346,共3页Chinese Imaging Journal of Integrated Traditional and Western Medicine

摘　　要：目的:研究肝动脉造影CT和经动脉门脉造影CT在肝癌介入治疗中的应用价值和意义。方法:10例原发性肝癌介入治疗前行肝动脉造影CT(CTHA)和经动脉门脉造影CT(CTAP)检查;术中行数字减影肝动脉造影(DSA)。结果:CTHA、CTAP联合检查与常规CT、DSA比较,分别多发现新癌灶11个(26/37)和12个(25/37)。准确判断非复发癌灶2个和1个坏死灶。结论:CTHA、CTAP是肝癌介入治疗前准确判断肿瘤数量和存活度最敏感和准确的方法,对于介入治疗方案的实施、疗效评价有很重要的作用。Objective：To investigate the application and significance of CT hepatic arteriography （CTHA） and CT during arterial portography （CTAP） in liver examination of interventional therapy of primary liver cancer. Methods： CTHA and CTPA were performed in 10 patients with primary hepatic cancer before percutaneous hepatic artery ehemoembolization （TACE）. Resuits： CTHA and CTPA discovered more new lesions than compared routine CT and DSA. Assessment of survival of neoplastic nodules and nontumor nodules were accurate. Conclusion： CTHA and CTAP are the most sensitive and accurate method for assessment of amount of neoplastic nodules and survival in examination of liver cancer before interventional therapy, and play an important role in determining program of interventional therapy and evaluating therapic effect.

关 键 词：CT动脉性门脉造影 CT肝动脉造影 诊断 肝肿瘤 检查 

分 类 号：R735.7[医药卫生—肿瘤] R815[医药卫生—临床医学]